Dynabeads™ FlowComp™ Mouse CD4 Kit
Invitrogen™

Dynabeads™ FlowComp™ Mouse CD4 Kit

This gentle and easy-to-use kit allows you to isolate flow-compatible mouse CD4+ T cells. Immediately after positive isolation, the beadsRead more
Have Questions?
Catalog NumberQuantity
11461D3 mL
Catalog number 11461D
Price (MXN)
-
Quantity:
3 mL
This gentle and easy-to-use kit allows you to isolate flow-compatible mouse CD4+ T cells. Immediately after positive isolation, the beads are released and removed from your cell sample. In this way, you avoid exposing your cells to potentially cytotoxic or immunogenic foreign substances like iron oxides or dextrans, a potential problem when working with biodegradable particles. In addition, your cells will not be exposed to the stress of being passed through a column.

You can expect a purity level of >85% and viability of >85% of mouse CD4+ cells.

Advantages:

• No risk of your results being affected by the isolation method
• Gentle tube-based method - no columns needed
• High purity, recovery and viability
• Bead-free cells - compatible with flow cytometry analysis
• Viable, bead-free CD4+ T-cells for direct use in any cell-based assay.

The isolated cells have the presumed profile of memory and naive CD4+ T cells, and show a high proliferation capacity. You will save time and money, and get increased confidence in your results.

Starting sample: Spleen or lymph node cells
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Cell TypeT Cells (CD4)
Isolation TechnologyPositive Isolation
No. of CellsProcesses ∼2 x 109 cells total
Output Viability>95%
Product LineDYNAL, Dynabeads, FlowComp
Purity or Quality GradeResearch Grade
Quantity3 mL
ReactivityMouse
Sample TypeLymph Node, Blood, Spleen
Shipping ConditionRoom Temperature
Starting Material Cell No.5 x 107 cells per isolation
Target SpeciesMouse
Product TypeSuperparamagnetic Beads
Unit SizeEach
Contents & Storage
The Kit Contains:
• 1 mL Antibody Mix
• 3 mL FlowComp™ Dynabeads™
• 40 mL FlowComp™ Release Buffer.

Store at: 2°C to 8°C.

Citations & References (1)

Citations & References
Abstract
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors.
Authors:Brody JD, Goldstein MJ, Czerwinski DK, Levy R,
Journal:Blood
PubMed ID:18812472
Ex vivo-expanded tumor-infiltrating lymphocytes infused into lymphodepleted recipients has clear antitumor efficacy. More practical sources of such antitumor lymphocytes would broaden the application of this approach. Previously, we described an in situ vaccination combining chemotherapy with intratumoral injection of CpG-enriched oligonucleotides, which induced T-cell immunity against established lymphoma. An ongoing ... More